|
|
||||||||
a Division of Cardiothoracic Surgery, Department of Surgery, University of Minnesota, Minneapolis, Minnesota
b Division of Cardiology, University of Minnesota, Minneapolis, Minnesota
Accepted for publication June 2, 2008.
* Address correspondence to Dr John, Division of Cardiothoracic Surgery, University of Minnesota, 420 Delaware St SE, MMC 207, Minneapolis, MN 55455 (Email: johnx008{at}umn.edu).
Presented at the Forty-fourth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 28–30, 2008.
Background: Pulsatile left ventricular assist devices (LVADs) are effective as bridge-to-transplant therapy, but they are limited by their large size and lack of durability. Smaller, more durable, continuous flow devices such as the HeartMate II LVAD are increasingly being used. The aim of this study is to report our single-center experience with this device as bridge-to-transplant therapy.
Methods: Overall, 47 patients received HeartMate II LVADs at our center from June 2005 to July 2007; 32 as bridge to transplant, 7 as destination therapy, and 8 as exchange therapy for a failed HeartMate XVE. We reviewed our experience with the device as bridge-to-transplant therapy and report on patient survival and adverse events.
Results: The mean age of the bridge-to-transplant patients was 50.75 ± 13.78 years; 10 (31.3%) were female. The cause of the underlying disease was ischemic in 18 patients (56.3%), idiopathic in 11 (34.4%), myocarditis in 1 (3.1%), postpartum cardiomyopathy in 1 (3.1%), and congenital heart disease in 1 (3.1%). The mean duration of HeartMate II support was 193.2 ± 139.9 days. At 30 days after HeartMate II placement, the patient survival was 96.9% by Kaplan-Meier analysis; at 6 months (alive or transplanted), 86.9%. Major adverse events included bleeding requiring reexploration in 5 patients (15.6%), right ventricular failure requiring right ventricular assist device support in 2 (6.3%), LVAD-related infections in 4 (12.5%), neurologic or thromboembolic events in 2 (6.3%), and gastrointestinal bleeding in 5 (15.6%). We noted one serious device malfunction (3.1%) resulting in the patient's death; in addition, 2 patients experienced pump thrombosis (6.3%).
Conclusions: Despite morbidity, use of the HeartMate II LVAD as bridge-to-transplant therapy is associated with excellent survival and low mortality rates. We found a marked decrease in morbidity related to right ventricular failure, to device-related infections, and to thromboembolic events. However, the requirements for anticoagulation therapy may be associated with increased mediastinal and gastrointestinal bleeding. Strategies to optimize anticoagulation therapy may further improve results for these critically ill patients.
This article has been cited by other articles:
![]() |
S. E. A. Felix, J. R. Martina, J. H. Kirkels, C. Klopping, H. Nathoe, E. Sukkel, N. Hulstein, F. Z. Ramjankhan, P. A. F. M. Doevendans, J. R. Lahpor, et al. Continuous-flow left ventricular assist device support in patients with advanced heart failure: points of interest for the daily management Eur J Heart Fail, February 3, 2012; (2012) hfs012v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Griffith, E. Jenkins, J. Stulak, T. Paugh, and F. Pagani Long-term use of the CentriMag(R) Ventricular Assist System as a right ventricular assist device: a case report Perfusion, January 1, 2012; 27(1): 65 - 70. [Abstract] [PDF] |
||||
![]() |
C. Heilmann, U. Geisen, F. Beyersdorf, L. Nakamura, G. Trummer, M. Berchtold-Herz, C. Schlensak, and B. Zieger Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients, Eur J Cardiothorac Surg, December 1, 2011; 40(6): 1328 - 1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. John, F. Kamdar, P. Eckman, M. Colvin-Adams, A. Boyle, S. Shumway, L. Joyce, and K. Liao Lessons Learned From Experience With Over 100 Consecutive HeartMate II Left Ventricular Assist Devices Ann. Thorac. Surg., November 1, 2011; 92(5): 1593 - 1600. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Healy, N. O. Mason, M. E. Hammond, B. B. Reid, S. E. Clayson, S. G. Drakos, A. G. Kfoury, A. N. Patel, D. A. Bull, D. Budge, et al. Allograft Rejection in Patients Supported With Continuous-Flow Left Ventricular Assist Devices Ann. Thorac. Surg., November 1, 2011; 92(5): 1601 - 1607. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. John, Y. Naka, N. G. Smedira, R. Starling, U. Jorde, P. Eckman, D. J. Farrar, and F. D. Pagani Continuous Flow Left Ventricular Assist Device Outcomes in Commercial Use Compared With the Prior Clinical Trial Ann. Thorac. Surg., October 1, 2011; 92(4): 1406 - 1413. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Slaughter, G. A. Giridharan, D. Tamez, J. LaRose, M. A. Sobieski, L. Sherwood, and S. C. Koenig Transapical miniaturized ventricular assist device: Design and initial testing J. Thorac. Cardiovasc. Surg., September 1, 2011; 142(3): 668 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Menon, G. Dohmen, A. H. Mahnken, and R. Autschbach Successful combined procedure of HeartMate II left ventricular assist device implantation and minimally invasive transapical aortic valve replacement J. Thorac. Cardiovasc. Surg., September 1, 2011; 142(3): 708 - 709. [Full Text] [PDF] |
||||
![]() |
M. Strueber, G. O'Driscoll, P. Jansz, A. Khaghani, W. C. Levy, G. M. Wieselthaler, and HeartWare Investigators Multicenter Evaluation of an Intrapericardial Left Ventricular Assist System J. Am. Coll. Cardiol., March 22, 2011; 57(12): 1375 - 1382. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. W. Skelley, J. G. Allen, G. J. Arnaoutakis, E. S. Weiss, N. D. Patel, and J. V. Conte The Impact of Volume Reduction on Early and Long-Term Outcomes in Surgical Ventricular Restoration for Severe Heart Failure Ann. Thorac. Surg., January 1, 2011; 91(1): 104 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Smith, B. Sun, D. Lindsey, and M. S. Firstenberg Surgical management of unusual gastrointestinal bleeding and a left ventricular assist device Interact CardioVasc Thorac Surg, November 1, 2010; 11(5): 612 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Crow, D. Chen, C. Milano, W. Thomas, L. Joyce, V. Piacentino III, R. Sharma, J. Wu, G. Arepally, D. Bowles, et al. Acquired von Willebrand Syndrome in Continuous-Flow Ventricular Assist Device Recipients Ann. Thorac. Surg., October 1, 2010; 90(4): 1263 - 1269. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Herman, J. D. Muehlschlegel, G. S. Couper, and E. Kelly Colonic perforation from left ventricular assist device: a rare complication Interact CardioVasc Thorac Surg, September 1, 2010; 11(3): 369 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Jakovljevic, R. S. George, D. Nunan, G. Donovan, R. S. Bougard, M. H. Yacoub, E. J. Birks, and D. A. Brodie The impact of acute reduction of continuous-flow left ventricular assist device support on cardiac and exercise performance Heart, September 1, 2010; 96(17): 1390 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. John, K. Liao, F. Kamdar, P. Eckman, A. Boyle, and M. Colvin-Adams Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices J. Thorac. Cardiovasc. Surg., August 1, 2010; 140(2): 447 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Russo, K. N. Hong, R. R. Davies, J. M. Chen, R. A. Sorabella, D. D. Ascheim, M. R. Williams, A. C. Gelijns, A. S. Stewart, M. Argenziano, et al. Posttransplant survival is not diminished in heart transplant recipients bridged with implantable left ventricular assist devices. J. Thorac. Cardiovasc. Surg., December 1, 2009; 138(6): 1425 - 1432.e3. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Pal, C. T. Klodell, R. John, F. D. Pagani, J. G. Rogers, D. J. Farrar, C. A. Milano, and for the HeartMate II Clinical Investigators Low Operative Mortality With Implantation of a Continuous-Flow Left Ventricular Assist Device and Impact of Concurrent Cardiac Procedures Circulation, September 15, 2009; 120(11_suppl_1): S215 - S219. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Adams, A. C. Anyanwu, J. Chikwe, and F. Filsoufi The Year in Cardiovascular Surgery J. Am. Coll. Cardiol., June 23, 2009; 53(25): 2389 - 2403. [Full Text] [PDF] |
||||
![]() |
S. E. Sandner, D. Zimpfer, P. Zrunek, A. Rajek, H. Schima, D. Dunkler, M. Grimm, E. Wolner, and G. M. Wieselthaler Renal Function and Outcome After Continuous Flow Left Ventricular Assist Device Implantation Ann. Thorac. Surg., April 1, 2009; 87(4): 1072 - 1078. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |